Detailed information for compound 172230

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 363.496 | Formula: C23H29N3O
  • H donors: 0 H acceptors: 1 LogP: 3.49 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)CN1CCN(CC1)CC(=O)N1[C@@H](C)Cc2c1cccc2
  • InChi: 1S/C23H29N3O/c1-18-7-9-20(10-8-18)16-24-11-13-25(14-12-24)17-23(27)26-19(2)15-21-5-3-4-6-22(21)26/h3-10,19H,11-17H2,1-2H3/t19-/m0/s1
  • InChiKey: BKDQVRCFIJMWOR-IBGZPJMESA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens dopamine receptor D2 Starlite/ChEMBL References
Homo sapiens dopamine receptor D4 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi bromodomain factor 2 protein 0.0488 0.0112 0.5
Schistosoma mansoni bromodomain containing protein 0.0488 0.0112 0.0112
Echinococcus granulosus fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Mycobacterium leprae Chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase). 0.143 0.1596 0.5
Echinococcus granulosus CREB binding protein 0.2827 0.3796 0.3726
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Mycobacterium ulcerans chorismate synthase 0.29 0.3912 0.5
Trichomonas vaginalis histone acetyltransferase gcn5, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.4216 0.5985 0.5939
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Loa Loa (eye worm) hypothetical protein 0.6764 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Loa Loa (eye worm) bromodomain containing protein 0.3037 0.4127 0.4061
Trypanosoma brucei bromodomain factor 2 protein, putative 0.0488 0.0112 0.5
Giardia lamblia Kinase, putative 0.3037 0.4127 1
Echinococcus multilocularis CREB binding protein 0.2079 0.2618 0.2534
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0488 0.0112 0.0112
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily 0.0642 0.0355 0.0245
Loa Loa (eye worm) hypothetical protein 0.1117 0.1103 0.1002
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Echinococcus multilocularis bromodomain containing 2 0.6764 1 1
Trichomonas vaginalis bromodomain containing protein, putative 0.4216 0.5985 0.5939
Echinococcus granulosus tm gpcr rhodopsin 0.0642 0.0355 0.0245
Leishmania major hypothetical protein, conserved,predicted bromodomain protein 0.0488 0.0112 0.5
Echinococcus multilocularis fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Entamoeba histolytica bromodomain-containing protein 0.3037 0.4127 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis conserved hypothetical protein 0.3727 0.5215 0.5161
Mycobacterium tuberculosis Probable chorismate synthase AroF (5-enolpyruvylshikimate-3-phosphate phospholyase) 0.143 0.1596 0.5
Brugia malayi Bromodomain containing protein 0.6764 1 1
Trichomonas vaginalis bromodomain containing protein, putative 0.3037 0.4127 0.4061
Brugia malayi hypothetical protein 0.2548 0.3358 0.3282
Schistosoma mansoni CREB-binding protein 1 (SmCBP1) 0.2827 0.3796 0.3796
Schistosoma mansoni helicase 0.0488 0.0112 0.0112
Schistosoma mansoni transcription initiation factor tfiid 0.0488 0.0112 0.0112
Toxoplasma gondii chorismate synthase, putative 0.29 0.3912 0.9463
Trichomonas vaginalis bromodomain-containing protein, putative 0.6764 1 1
Leishmania major hypothetical protein, conserved 0.0488 0.0112 0.5
Loa Loa (eye worm) CBP-B 0.21 0.2651 0.2567
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Entamoeba histolytica bromodomain-containing protein 0.3037 0.4127 1
Trichomonas vaginalis conserved hypothetical protein 0.4216 0.5985 0.5939
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Echinococcus granulosus bromodomain containing 2 0.6764 1 1
Leishmania major hypothetical protein, conserved 0.0488 0.0112 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Entamoeba histolytica bromodomain-containing protein 0.3037 0.4127 1
Onchocerca volvulus 0.3037 0.4127 1
Trypanosoma brucei Bromodomain, putative 0.0488 0.0112 0.5
Schistosoma mansoni bromodomain containing protein 0.0488 0.0112 0.0112
Brugia malayi amidase 0.1079 0.1043 0.0942
Schistosoma mansoni polybromo-1 0.0488 0.0112 0.0112
Trypanosoma cruzi bromodomain-containing protein 3 0.0488 0.0112 0.5
Plasmodium falciparum chorismate synthase 0.29 0.3912 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trypanosoma cruzi hypothetical protein, conserved 0.0488 0.0112 0.5
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Loa Loa (eye worm) hypothetical protein 0.1079 0.1043 0.0942
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Schistosoma mansoni bromodomain containing 0.0488 0.0112 0.0112
Toxoplasma gondii bromodomain-containing protein 0.3037 0.4127 1
Trypanosoma cruzi Bromodomain factor 1 0.0488 0.0112 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trypanosoma brucei Bromodomain factor 1 0.0488 0.0112 0.5
Schistosoma mansoni zinc finger protein 0.0488 0.0112 0.0112
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.6764 1 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Echinococcus granulosus CREB binding protein 0.1915 0.2359 0.2273
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Brugia malayi TAZ zinc finger family protein 0.2827 0.3796 0.3726
Trypanosoma brucei AAA ATPase, putative 0.0488 0.0112 0.5
Trichomonas vaginalis conserved hypothetical protein 0.3037 0.4127 0.4061
Plasmodium vivax chorismate synthase 0.29 0.3912 1
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Schistosoma mansoni bromodomain containing protein 0.0488 0.0112 0.0112
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Schistosoma mansoni bromodomain-containing protein 3 brd3 0.6764 1 1
Chlamydia trachomatis chorismate synthase 0.29 0.3912 0.5
Trichomonas vaginalis bromodomain-containing protein, putative 0.4216 0.5985 0.5939
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Leishmania major DNA-binding protein, putative,predicted bromodomain protein 0.0488 0.0112 0.5
Schistosoma mansoni amidase 0.1079 0.1043 0.1043
Echinococcus multilocularis Bromodomain containing protein 0.3037 0.4127 0.4061
Trypanosoma brucei Bromodomain, putative 0.0488 0.0112 0.5
Schistosoma mansoni phd finger protein 0.0488 0.0112 0.0112
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Echinococcus multilocularis fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein 4, brd4, putative 0.3037 0.4127 0.4061
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Trypanosoma cruzi Bromodomain, putative 0.0488 0.0112 0.5
Trypanosoma brucei Bromodomain, putative 0.0488 0.0112 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.1079 0.1043 0.0942
Schistosoma mansoni fatty-acid amide hydrolase 0.1079 0.1043 0.1043
Trichomonas vaginalis bromodomain-containing protein, putative 0.3037 0.4127 0.4061
Trichomonas vaginalis bromodomain-containing protein, putative 0.4216 0.5985 0.5939
Schistosoma mansoni hypothetical protein 0.0488 0.0112 0.0112
Schistosoma mansoni CREB-binding protein 2 0.2827 0.3796 0.3796

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 64 nM Binding affinity towards Dopamine type 4 receptor was determined by competitive displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 2364 nM Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 64 uM Binding affinity towards Dopamine type 4 receptor was determined by competitive displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513
Ki (binding) = 906 uM Binding affinity towards Alpha-1 adrenergic receptor was determined by competitive displacement assays using rat brain homogenate with [3H]-prazosin as the competitive ligand ChEMBL. 12372513
Ki (binding) = 906 uM Binding affinity towards Alpha-1 adrenergic receptor was determined by competitive displacement assays using rat brain homogenate with [3H]-prazosin as the competitive ligand ChEMBL. 12372513
Ki (binding) = 2364 uM Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand ChEMBL. 12372513

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.